Results 121 to 130 of about 116,766 (274)
Sami A Alawfi Clinical Laboratory Sciences Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi ArabiaCorrespondence: Sami A Alawfi, Email SAOFEEY@taibahu.edu.saIntroduction: Candidiasis, commonly known as yeast infection ...
Alawfi SA
doaj
Oropharyngeal candidiasis is a common occurrence in the course of Human Immunodeficiency Virus (HIV) disease progression and it is predictive of immunosuppression.
Emumwen Ehiosu Favour, Ogefere Helen Oroboghae, Omosigho Omoruyi Pius*, Emumwen Evbaziegbere Gidion
doaj
Rational treatment for vulvovaginal candidiasis caused by resistant Candida species [PDF]
G.B. Dikke F.I. Inozemtsev Academy of Medical Education, St. Petersburg, Russian Federation In recent decade, growing incidence (24–29%) of vulvovaginal candidiasis caused by Candida non-albicans is reported.
G.B. Dikke
doaj
Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis. [PDF]
There are limited treatment options for immunosuppressed patients with lethal invasive fungal infections due to Fusarium and Scedosporium Manogepix (MGX; APX001A) is a novel antifungal that targets the conserved Gwt1 enzyme required for localization of ...
Alkhazraji, Sondus +8 more
core +1 more source
Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study
In Chinese patients with moderate to severe plaque psoriasis, bimekizumab treatment was well tolerated and led to significantly higher clinical response rates versus placebo, including complete skin clearance. These findings were consistent with global studies and suggest that bimekizumab is an effective treatment option for Chinese people living with ...
Lin Cai +11 more
wiley +1 more source
OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta +4 more
wiley +1 more source
Microbiome predictors of candidiasis following corticosteroids in oral lichen planus
Objectives: Topical corticosteroid therapy (TCST) is the primary treatment for oral lichen planus (OLP), but an increased risk of oral candidiasis remains a common adverse effect.
Thritamon Kabtum +6 more
doaj +1 more source
An individualised, item‐specific, nurse‐implemented OHC plan guided by structured screening and clinical assessment improved gingival inflammation and oral hygiene compared with routine care in adults with ABI within a multidisciplinary neurorehabilitation setting.
Mohit Kothari +6 more
wiley +1 more source
The Expression and Potential Role of MicroRNAs in Oral Lichen Planus
ABSTRACT Background Oral lichen planus (OLP) is a chronic T‐cell‐mediated immune disease of unknown aetiology. MicroRNA (miRNAs) are short non‐coding RNAs capable of regulating mRNA and may have roles in T‐cell‐related diseases. The aim of this study was to investigate the profile of miRNAs in OLP patients and its interaction with potential target ...
Mousa Ali Heba +3 more
wiley +1 more source
Abstract Purpose There is a need for effective solutions for the persistent prevalence of denture stomatitis (DS) in denture‐wearing populations. This study assessed the impact of nanohydroxyapatite (nanoHAP) nanoparticles on Candida albicans biofilm formation on milled polymethylmethacrylate (PMMA) denture bases.
Cynthia U. Udeh +8 more
wiley +1 more source

